Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.

Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.

OBJECTIVES: The Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) program was initiated by the International Organization for the Study of Inflammatory Bowel Diseases (IOIBD). It examined potential treatment targets for inflammatory bowel disease (IBD) to be used for a "treat...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính:	Peyrin-Biroulet, L, Sandborn, W, Sands, B, Reinisch, W, Bemelman, W, Bryant, R, D'Haens, G, Dotan, I, Dubinsky, M, Feagan, B, Fiorino, G, Gearry, R, Krishnareddy, S, Lakatos, P, Loftus, E, Marteau, P, Munkholm, P, Murdoch, T, Ordás, I, Panaccione, R, Riddell, R, Ruel, J, Rubin, D, Samaan, M, Siegel, C, Silverberg, MS, Stoker, J, Schreiber, S, Travis, S, Van Assche, G, Danese, S, Panes, J, Bouguen, G, O'Donnell, S, Pariente, B, Winer, S, Hanauer, S, Colombel, J
Định dạng:	Journal article
Ngôn ngữ:	English
Được phát hành:	Nature Publishing Group 2015

Những quyển sách tương tự

The Crohn's disease–ulcerative colitis clinical appraisal update: emerging trends in clinical practice
Bằng: Sandborn, W, et al.
Được phát hành: (2016)

Development of the Paris definition of early Crohn's disease for disease-modification trials: results of an international expert opinion process.
Bằng: Peyrin-Biroulet, L, et al.
Được phát hành: (2012)

Development of red flags index for early referral of adults with symptoms and signs suggestive of Crohn’s disease: an IOIBD initiative
Bằng: Danese, S, et al.
Được phát hành: (2015)

Development of an index to define overall disease severity in IBD
Bằng: Siegel, C, et al.
Được phát hành: (2016)

Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease.
Bằng: D'Haens, G, et al.
Được phát hành: (2009)

Biologic Therapies: From Complexity to Clinical Practice in a Changing Environment
Bằng: Remo Panaccione, et al.
Được phát hành: (2015-12-01)

Evolving concepts in Phase I and II Drug Development for Crohn's Disease.
Bằng: Jairath, V, et al.
Được phát hành: (2016)

Development of the Crohn's disease digestive damage score, the Lemann score.
Bằng: Pariente, B, et al.
Được phát hành: (2011)

Biomarker correlation with endoscopic outcomes in patients with Crohn's disease: data from CALM
Bằng: Reinisch, W, et al.
Được phát hành: (2018)

Evolving concepts in phases I and II drug development for Crohn's Disease
Bằng: Jairath, V, et al.
Được phát hành: (2016)

Standardizing scoring conventions for Crohn’s disease endoscopy: An international RAND/UCLA appropriateness study
Bằng: Khanna, R, et al.
Được phát hành: (2023)

The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis
Bằng: Travis, S, et al.
Được phát hành: (2013)

Biosimilars in IBD: hope or expectation?
Bằng: Gecse, K, et al.
Được phát hành: (2013)

Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus
Bằng: Vuitton, L, et al.
Được phát hành: (2017)

American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006.
Bằng: Clark, M, et al.
Được phát hành: (2007)

A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998.
Bằng: Gasche, C, et al.
Được phát hành: (2000)

Reliability and initial validation of the ulcerative colitis endoscopic index of severity.
Bằng: Travis, S, et al.
Được phát hành: (2013)

The Impact of Clinical Information on the Assessment of Endoscopic Activity: Characteristics of the Ulcerative Colitis Endoscopic Index Of Severity [UCEIS].
Bằng: Travis, S, et al.
Được phát hành: (2015)

Tight control for Crohn's disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial
Bằng: Panaccione, R, et al.
Được phát hành: (2019)

Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS).
Bằng: Travis, S, et al.
Được phát hành: (2012)

Review article: defining remission in ulcerative colitis.
Bằng: Travis, S, et al.
Được phát hành: (2011)

European evidence-based Consensus on the management of ulcerative colitis: Current management.
Bằng: Travis, S, et al.
Được phát hành: (2008)

Shorter Crohn’s Disease Duration Is Associated With Better Clinical and Endoscopic Outcomes With Risankizumab in Phase 3 Studies
Bằng: Laurent Peyrin-Biroulet, et al.
Được phát hành: (2024-01-01)

Induction of clinical and colonoscopic remission of mild-to-moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies.
Bằng: Sandborn, W, et al.
Được phát hành: (2015)

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial.
Bằng: Colombel, J, et al.
Được phát hành: (2017)

CORE-IBD: a multidisciplinary international consensus initiative to develop a core outcome set for randomized controlled trials in inflammatory bowel disease
Bằng: Ma, C, et al.
Được phát hành: (2022)

Effect of adalimumab dose escalation on clinical, health-related quality of life, treatment satisfaction and work productivity outcomes among patients with ulcerative colitis in a clinical practice setting: results from INSPIRADA
Bằng: Travis, S, et al.
Được phát hành: (2017)

Effect of adalimumab on extraintestinal manifestations among patients with ulcerative colitis in a clinical practice setting: results from INSPIRADA
Bằng: Travis, S, et al.
Được phát hành: (2017)

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?
Bằng: D'Haens, G, et al.
Được phát hành: (2011)

The London position statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: safety.
Bằng: Van Assche, G, et al.
Được phát hành: (2011)

Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study.
Bằng: Travis, S, et al.
Được phát hành: (2014)

Budesonide MMX® for the induction of remission of mild to moderate ulcerative colitis: a pooled safety analysis.
Bằng: Lichtenstein, G, et al.
Được phát hành: (2015)

Lymphoma risk and overall safety profile of Adalimumab in patients with Crohn's disease with up to 6 years of follow-up in the pyramid
Bằng: D'Haens, G, et al.
Được phát hành: (2018)

Endoscopic and deep remission at 1 year prevents disease progression in early Crohn’s disease: long-term data from CALM
Bằng: Yzet, C, et al.
Được phát hành: (2019)

Central Reading of Endoscopy Endpoints in Inflammatory Bowel Disease Trials.
Bằng: Gottlieb, K, et al.
Được phát hành: (2015)

The real-world global use of patient-reported outcomes for the care of patients with inflammatory bowel disease
Bằng: Horrigan, JM, et al.
Được phát hành: (2023)

Benzimidazoles promote anti-TNF mediated induction of regulatory macrophages and enhance therapeutic efficacy in a murine model
Bằng: Wildenberg, M, et al.
Được phát hành: (2017)

Antieosinophil Therapeutics
Bằng: Straumann, A, et al.
Được phát hành: (2013)

Reliability among central readers in the evaluation of endoscopic disease activity in pouchitis
Bằng: Samaan, MA, et al.
Được phát hành: (2018)

Effect of adalimumab on clinical outcomes and health-related quality of life among patients with ulcerative colitis in a clinical practice setting: Results from inspirADA
Bằng: Travis, S, et al.
Được phát hành: (2017)